N-Acetylneuraminic Acid (Neu5Ac): A Comprehensive Reference
1. Identity and Chemical Characterization
Names and Chemical Classification
N-acetylneuraminic acid (abbreviated Neu5Ac, NANA, or NeuAc) is the predominant naturally occurring form of sialic acid in humans and many mammalian species. It is the predominant sialic acid found in human cells and many mammalian cells. Additional common names and synonyms include sialic acid, lactaminic acid, and the colloquial Chinese designation bird's nest acid. Accepted synonyms include SIALIC ACID, NEU5AC, NAN, NANA, Acetylneuraminic acid, NeuAc, LACTAMINIC ACID, and (-)-N-ACETYLNEURAMINIC ACID.
Sialic acids are a family of α-keto aldonic acids with a nine‑carbon backbone, members of which include neuraminic acid and 2-keto-3-deoxy-nonulosonic acid. N-acetylneuraminic acid is an N-acyl derivative of neuraminic acid — an amino sugar derivative — derived biochemically from N-acetylmannosamine and pyruvic acid. Its CAS registry number is 131-48-6.
More than 50 different types of sialic acid have been identified, and N-acetylneuraminic acid (Neu5Ac), N-glycolylneuraminic acid (Neu5Gc), and deaminoneuraminic acid (KDN) are the most abundant naturally occurring forms. Most sialic acids are composed of N-acetylneuraminic acid (Neu5Ac, accounting for >99%), and "sialic acid" is its most commonly used name.
This residue is negatively charged at physiological pH and is found in complex glycans on mucins and glycoproteins at the cell membrane. In solution, Neu5Ac is mainly (over 90%) in the beta-anomeric form; however, the alpha-anomer is the form found when sialic acid is bound to glycans.
Natural Sources
Sialic acids are negatively charged functional monosaccharides present in a wide variety of natural sources — plants, animals, and microorganisms. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria.
Dietary and biological sources of Neu5Ac include:
- Human milk: Human milk is noteworthy for containing exceptionally high levels of sialic acid glycoconjugates; the predominant form of sialic acid in human milk is Neu5Ac. Although sialic acid was abundant in human milk during the first month of lactation, its concentration decreased by 70% over the course of 3 months.
- Edible bird's nest (EBN): Traditionally used as a food delicacy and as an important ingredient in traditional Chinese medicine, the major components of edible bird's nest (EBN) are mainly carbohydrates, glycoproteins, and trace elements; sialic acid constitutes approximately 9% of the carbohydrate fraction of EBN.
- Red meat and animal organs: Sialic acids are acidic monosaccharides and red meat is a notable dietary source for humans. Neu5Ac has been measured in muscle, kidney, lung, liver, heart, spleen, and fat tissue across multiple animal species.
- Eggs, bovine milk, porcine milk, and deer antler: Sialic acid has been reported to be naturally present in many animal sources, including EBN, human breast milk, hen egg, bovine milk, porcine milk, and deer antler.
Neu5Ac is found in various biological tissues mainly in the form of cell membrane glycoprotein and glycolipid, and is most concentrated in cerebrospinal fluid (CSF) and colostrum.
Notably, humans cannot synthesize N-glycolylneuraminic acid (Neu5Gc) from Neu5Ac. Whereas humans only synthesize Neu5Ac and its derivatives, most non-human animals can convert Neu5Ac to N-glycolylneuraminic acid (Neu5Gc) and its derivatives.
Common Forms and Preparations
Production strategies include extraction from natural sources, chemical synthesis, polymer decomposition, enzymatic synthesis, whole-cell catalysis, and de novo biosynthesis via microorganism fermentation.
The traditional method is to extract Neu5Ac from natural products such as edible bird's nest, eggs, and milk; however, extraction from natural raw materials has many disadvantages, including difficulties in obtaining materials, complex extraction processes, low Neu5Ac content, low recovery rate, and a requirement for specific equipment, making it difficult to meet industrial-scale demand.
In the enzymatic synthesis pathway, the first step is to isomerize GlcNAc to ManNAc through the action of N-acetyl-D-glucosamine-2-epimerase (AGE); ManNAc and pyruvate then condense to form Neu5Ac under the action of N-acetylneuraminate lyase (NanA). Commercial dietary supplement preparations are available as powders, capsules, and as ingredients in fortified infant formulas, dairy products, and functional foods.
2. Traditional and Historical Use
East Asian Medicinal Tradition: Edible Bird's Nest
The most extensively documented historical use of a Neu5Ac-rich food source occurs within Chinese medicinal cuisine. Historically, sialic acid-rich foods such as edible bird's nest have been prized in East Asian remedies for their rejuvenating and immune-supporting properties; for centuries, edible bird's nest — especially valued in Chinese medicinal cuisine — was believed to enhance vitality, support respiratory health, and promote overall well-being.
Residents of China, Taiwan, Hong Kong, and Singapore have been relying on edible bird's nest for centuries; it is typically utilized as a remedy for illness and is also consumed by the elderly and those seeking to enhance skin health. The health benefits observed were later attributed in part to the high sialic acid content of these nests.
The neurological rationale for traditional Chinese medicine's recommendation of bird's nest for pregnancy and infant development is supported by sialic acid's incorporation into brain gangliosides and its role in synaptic function — an area where traditional application has been most directly validated by modern molecular biology.
Animal Milks in Folk Medicine
In various folk remedies, animal milks — particularly from goats and camels — were recommended for infant nutrition and convalescence, conveying protection and healthy development, benefits now linked to the presence of sialic acid in these milks.
Isolation History
Sialic acid (known as N-acetylneuraminic acid) was originally isolated from bovine mandibular salivary gland mucin by a scientist named Blix. The subsequent enzymatic synthesis of Neu5Ac from N-acetylmannosamine and pyruvic acid has been known since the 1960s, with the reaction catalyzed by N-acetylneuraminic acid pyruvate lyase (EC 4.1.3.3).
3. Chemistry, Key Constituents, and Mechanisms of Action
Structural Position and Glycoconjugate Role
Neu5Ac is one of over thirty known sialic acid analogs and is the predominant form of sialic acid in humans; it is presented as the terminal residue on surface-exposed glycans, glycoproteins, and glycolipids. It is an important constituent of glycoproteins and glycolipids.
Neu5Ac residues are also found in glycolipids known as gangliosides, a crucial component of neuronal membranes found in the brain. In human milk, approximately 70–83% of all sialic acid is bound to human milk oligosaccharides (HMOs), 14–28% is bound to glycoproteins, and 0.2–0.4% to glycolipids, whereas the free form constitutes only 2–3%.
Cell Recognition and Immune Signaling
Sialic acids play crucial roles in cell surface glycans of both eukaryotic and prokaryotic organisms, mediating various biological processes including cell–cell interactions, development, immune response, oncogenesis, and host–pathogen interactions.
Sialic acid is recognized by immunoinhibitory sialic acid-binding immunoglobulin-like lectins (Siglecs) to prevent autoimmunity. This mechanism means that Neu5Ac on the surface of the body's own cells signals to immune effector cells that they are "self," preventing unwanted immune attack. Interestingly, select human pathogenic microbes have evolved to express this human Neu5Ac epitope on their own cellular surface to evade host immune surveillance and clearance.
Neurological Mechanisms
Sialic acid belongs to a family of nine-carbon sugar molecules that often attach to the glycoproteins and gangliosides of neuronal membranes; among all organs in mammals, the human central nervous system contains the highest amount of sialic acid, which plays a structural and functional role in brain development.
N-acetylneuraminic acid, as an essential component of synapses, plays a critical role in neuronal differentiation, growth, and regeneration, supporting synapse transmission and maintaining normal cell function, thereby affecting learning and memory. Mutations in N-acetylneuraminic acid synthase (NANS) result in the absence of both sialic acid and protein polysialylation, notably reducing the proliferation and expansion of neural progenitors, dysregulating neural migration and differentiation, disturbing synapse formation, and weakening neuronal activity.
Sialic acid occurs in large amounts in human milk oligosaccharides and is an essential component of brain gangliosides and sialylated glycoproteins, particularly as precursors for the synthesis of polysialic acid (polySia) — a glycan that post-translationally modifies cell membrane-associated neural cell adhesion molecules (NCAM).
Exogenous free sialic acid can cross the blood–brain barrier (BBB) and enter various tissues. This pharmacokinetic property is relevant for its potential as a dietary or supplemental agent affecting brain function.
Antiviral Activity via Receptor Occupation
The first step in influenza virus infection is the binding of hemagglutinin to sialic acid-containing glycans present on the cell surface; over 50 different sialic acid modifications are known, of which Neu5Ac and Neu5Gc are the two main species. Neu5Ac acts as a receptor for influenza viruses, allowing attachment to mucous cells via hemagglutinin — an early step in acquiring influenza virus infection. This dual role — Neu5Ac as both a viral attachment receptor and as a component of the protective mucus layer — underlies its complex relationship with host–pathogen dynamics. Neu5Ac is also a key precursor for producing anti-influenza viral drugs such as zanamivir and oseltamivir.
Gastrointestinal Mechanisms
In the GI tract, sialic acids are found in the terminal location of mucin glycan chains constituting the mucus layer, and also come from human milk oligosaccharides in the infant gut or from meat-based foods in adults; the repartition of sialic acid in the GI tract influences gut microbiota composition and pathogen colonization.
Sialylated glycoproteins and glycolipids in milk regulate the intestinal microbial ecosystem and prevent development of neonatal diseases by promoting probiotic growth and metabolism, inhibiting pathogen adhesion, inducing intestinal epithelial differentiation, promoting intestinal maturation, and optimizing immune function.
N-acetylneuraminic acid can enhance intestinal absorption of minerals and vitamins and promote bone development. Neu5Ac peptides can prevent intestinal toxins and pathogenic bacteria from binding to intestinal mucosal cells, thereby improving the antibacterial, detoxifying, and antiviral capabilities of the intestine.
Cardiometabolic and Hematological Roles
N-acetylneuraminic acid is a recognized biomarker of cardiometabolic diseases. Elevated serum sialic acid is a biomarker of cardiometabolic diseases, where it is thought to be a consequence of long-term inflammation. Since Neu5Ac adheres to the surface of red blood cells, it can protect red blood cells and prevent unnecessary cell interactions in blood circulation, making it critical in regulating the longevity of these blood components and maintaining homeostasis.
Biosynthesis
Neu5Ac is the most common sialic acid in the human organism and also the precursor for all other sialic acid derivatives; its biosynthesis begins in the cytosol with uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) as its starting component. Sialic acid is present in all vertebrates, essentially exists in all tissues, and can be synthesized de novo in the body.
4. Scientific Evidence by Area of Use
4.1 Brain Development and Cognitive Function
This is the most extensively studied area of Neu5Ac research, though evidence in humans remains predominantly indirect and inferential from animal models.
Mechanistic and animal evidence: Several studies showed that maternal sialic acid supplementation enhances offspring intelligence and cognition performance in rodents and pigs. The study of Morgan and Winick demonstrated that improvement in cognitive ability after administering sialic acid to rat pups correlated with increased sialic acid levels in the brain, and this benefit was shown to persist into adulthood. A study supplementing piglets with casein glycomacropeptide (CGMP), containing 60 mg/g sialic acid, for 5 weeks found that piglets fed with higher doses showed better performance in learning ability compared to those fed lower doses.
A Frontiers in Nutrition study (2021) evaluated the effects of free-form Neu5Ac administered to pregnant rats or rat pups. The study administered N-acetylneuraminic acid (Neu5Ac) in free form to 40 male 21-day-old rat pups and 20 15-day-pregnant rats, randomized into four Neu5Ac-treated groups (0, 10, 20, and 40 mg/kg); Morris water maze and shuttle box tests were performed on day 100 to evaluate cognitive performance, while Neu5Ac levels in the cerebral cortex and hippocampus were measured by HPLC-FLD.
Maternal EBN supplementation during pregnancy and lactation periods enhanced the levels of sialic acid in maternal mouse milk, which was associated with an increased level of brain-derived neurotrophic factor (BDNF) gene among their generations.
Human genetic evidence: Biallelic genetic variants in N-acetylneuraminic acid synthase (NANS), a critical enzyme in endogenous sialic acid biosynthesis, are clinically associated with neurodevelopmental disorders. Defects in sialic acid transfer and transporter due to genetic deficiencies of ST3GAL3, ST3GAL5, and SLC35A1 cause infantile epilepsy, attention deficit, hyperactivity disorder, and developmental delays.
Human milk context: The early stages of neurodevelopment in infants are crucial for establishing neural structures and synaptic connections that influence brain biochemistry well into adulthood; this postnatal period of rapid neural growth places an unusually high demand on the intracellular pool of nutrients and biochemical precursors.
Evidence strength: The causal relationship between dietary Neu5Ac supplementation and improved cognition is well established in animal models. Direct human clinical trial evidence remains limited. Further clinical studies and efficacy data are desirable to understand the role of human milk oligosaccharides in human brain and cognitive development.
4.2 Infant Formula and Neonatal Nutrition
Over 200 distinct types of HMOs have been characterized, with approximately 70–75% being neutral HMOs and 10–30% being sialylated HMOs, distinguished by the presence of a sialic acid molecule at the terminal position. Neu5Ac is the only form of sialic acid found in human milk, while the milk of other mammals may also contain Neu5Gc-bound oligosaccharides.
Supplementation of infant formula with five HMOs including the sialylated forms 3′-SL and 6′-SL at a total natural concentration of 5.75 g/L induced distinct shifts in β-diversity, aligning the microbial composition more closely with that of breastfed infants. Recent clinical studies have focused on supplementation of infant formulas with manufactured HMOs to replicate some of the benefits observed in breastfed infants.
Evidence strength: There is growing but still evolving clinical evidence that sialylated HMOs in infant formula shift gut microbiota composition toward breastfed-infant profiles. Effects on long-term cognitive outcomes in human infants have not yet been conclusively established by direct randomized controlled trials of Neu5Ac supplementation specifically.
4.3 Gut Microbiota Modulation
Recent studies show that HMOs play an essential role in regulating neonatal intestinal microecology; among these HMOs, approximately 10–30% of oligosaccharides are sialylated. HMOs are not directly digestible by humans; instead, they serve as prebiotics, fostering the growth of beneficial bacteria — particularly Bifidobacteria — in the infant's gut, modulating the immune system, and supporting infant growth and cognitive development.
A 2024 human intervention study examined sialic acid-based probiotic supplementation in lactating mothers. Although sialic acid was abundant in human milk during the first month of lactation, its concentration decreased by 70% over the course of 3 months; sialic acid can be synthesized de novo, but this process may not be sufficient for HMO biosynthesis by mothers or infant development during lactation.
Due to their structural similarity with mucosal glycans, sialylated HMOs act as soluble decoy receptors, inhibiting the adhesion of pathogenic microorganisms or bacterial toxins to host cell receptors.
Evidence strength: Preclinical evidence and early clinical studies support the role of sialylated oligosaccharides in shaping neonatal gut microbiota. Evidence in adults is largely mechanistic and preclinical.
4.4 Antiviral Activity
Animal models with α2,6-linked Neu5Ac in the upper respiratory tract, similar to humans, are preferred to enable and mimic infection with unadapted human influenza A viruses. This finding underlies the design of neuraminidase inhibitor drugs.
The well-known neuraminidase inhibitors oseltamivir and zanamivir mimic the binding mode of the transition state analogue 2-deoxy-2,3-dehydro-N-acetylneuraminic acid (DANA) as a natural substrate within the catalytic site. Regarding free Neu5Ac as a supplement and antiviral, the evidence base is animal/in vitro. As an excellent immune system moderator, sialic acid affects the flow resistance of mucus, which in turn repels bacteria, viruses, and other harmful microbes.
Evidence strength: The antiviral pharmacology of Neu5Ac as a precursor to antivirals (oseltamivir, zanamivir) is firmly established. Evidence for supplemental free Neu5Ac as an antiviral agent in humans is currently limited to animal and in vitro models and is considered preliminary.
4.5 Cardiometabolic Effects: Inflammation, Lipids, and Insulin Resistance
A rat study published in PMC (Universiti Putra Malaysia, 2015) tested the hypothesis that dietary Neu5Ac could improve cardiometabolic outcomes. A high-fat diet (HFD) supplemented with Neu5Ac (50 or 400 mg/kg BW/day) was compared with HFD + simvastatin (10 mg/kg BW/day) or HFD alone for 12 weeks. Results indicated that low and high doses of sialic acid improved metabolic indices, although only oral glucose tolerance, serum triglycerides, leptin, and adiponectin were significantly better than in the HFD and HFD + simvastatin groups (P < 0.05).
A related rat study investigated Neu5Ac's effect on high-fat diet-induced inflammation and oxidative stress. High-fat diet-fed rats with or without simvastatin or Neu5Ac (50 and 400 mg/kg/day) were followed for 12 weeks. Studies have indicated that supplementation with Neu5Ac has been shown to promote brain development and improve salivation, while research on cardiometabolic effects has yielded mixed results.
Evidence strength: Evidence for cardiometabolic effects is preliminary and based exclusively on animal models. No human clinical trials specifically addressing Neu5Ac supplementation for insulin resistance, dyslipidemia, or inflammation have been identified in the peer-reviewed literature.
4.6 Alzheimer's Disease and Neurodegeneration
A 2024 mouse model study (PMC) investigated the effects of sialic acid on Alzheimer's disease pathology. Male 2×Tg-AD mice were divided into AD control and groups treated with 17 mg/kg, 84 mg/kg, or 420 mg/kg of sialic acid, alongside wild-type control and wild-type + 420 mg/kg sialic acid groups. Many studies support the idea that sialic acid can enhance brain development, cognition, and learning behavior in animals.
Medical research has shown that sialic acid can improve the learning behavior of animals, help brain development and memory formation in newborns and premature infants, may promote synapse formation, and strengthen the development of the nervous system. Thus, sialic acid may have therapeutic potential for Alzheimer's disease, but there are few reports about this application.
Evidence strength: All evidence for Neu5Ac in Alzheimer's disease or neurodegeneration remains preclinical (animal models and in vitro). No human clinical trials have been completed.
4.7 Cancer Biology
The relationship between Neu5Ac and cancer is complex, with sialylation playing roles in both tumor progression and immune evasion mechanisms. The main function of the polysialic acid (polySia) modification on NCAM is known to be associated with cancer and tumor progression. Whilst high levels of polySia-NCAM are expressed during development, peripheral adult organs do not express polySia-NCAM; however, tumors of neural crest origin re-express polySia-NCAM, and its occurrence correlates with aggressive and invasive disease and poor clinical prognosis in cancer types including small cell lung cancer, pancreatic cancer, and neuroblastoma.
Deviating sialylation of glycan structures influences key processes during tumor progression such as invasion and metastasis; some sialylated glycans are useful prognostic markers of malignant disease states. In breast cancer, metabolomics investigations have demonstrated a significant association between heightened sialic acid metabolism and highly metastatic tumors.
Polysialic acid-modified liposomes have been used as a targeted drug delivery system to enhance anti-cancer efficiency; moreover, antibodies against siglec-15 — a sialic acid-binding protein and T cell depressor — are expected to apply to cancer immunotherapy, offering a therapeutic tool for patients resistant to current anti-PD-1/PD-L1 therapy.
Evidence strength: Sialic acid biology is deeply intertwined with cancer pathophysiology. However, this work is primarily mechanistic and translational; exogenous supplementation of Neu5Ac has not been clinically validated as a cancer treatment or preventive. The relationship between dietary Neu5Ac and cancer risk requires further human investigation.
5. Body Systems and Health Areas
- Central nervous system: Structural component of gangliosides and polySia-NCAM; essential for neural development, synaptogenesis, learning, and memory.
- Immune system: Sialic acids are widely applied as intestinal antibacterials, antivirals, anti-oxidative agents, food ingredients, and detoxification agents. Siglec-mediated self/non-self discrimination.
- Gastrointestinal tract: Terminal residue on mucin glycans forming the protective mucus layer; prebiotic function via sialylated HMOs; inhibition of pathogen adhesion.
- Cardiovascular system: Biomarker of cardiometabolic disease; proposed role in resialylation of vascular endothelium to modulate atherosclerosis.
- Hematological system: Present on erythrocyte surfaces, modulating red blood cell longevity and preventing inappropriate cell–cell interactions.
- Respiratory tract: Present in mucus of the respiratory tract; serves as an attachment receptor for influenza hemagglutinin.
- Oncology: Complex dual role — sialic acid overexpression on tumor surfaces can promote immune evasion and metastasis; polySia-NCAM is a prognostic biomarker in several cancers.
6. Dosage Forms and Dosages Reported in Studies
Neu5Ac is available commercially as a purified powder, in capsule form, and as a fortifying ingredient added to infant formulas and functional foods.
- Animal cognitive studies (rat model): Neu5Ac was administered to rat pups and pregnant rats at doses of 10, 20, and 40 mg/kg body weight.
- Animal cardiometabolic studies (rat model): Neu5Ac was fed at 50 or 400 mg/kg BW/day alongside high-fat diet for 12 weeks.
- Alzheimer's mouse model: AD mice received 17 mg/kg, 84 mg/kg, or 420 mg/kg of sialic acid.
- Infant formula clinical supplementation: Sialylated HMOs (3′-SL and 6′-SL) were used as components of a five-HMO formula at a total concentration of 5.75 g/L.
- EFSA novel food assessment context: The NOAEL established in a subchronic study was 493 mg/kg body weight per day; the anticipated daily intake for fortified foods and food supplements was considered to be in the range of exposure to free NANA from the consumption of early human milk.
No standardized human supplementation dose for Neu5Ac has been established by regulatory bodies. Reported dosages across studies vary widely by population, route of administration, and study design.
7. Safety Considerations
Regulatory Assessment
According to a European Food Safety Authority (EFSA) evaluation, the information on the composition, specifications, stability, and production process of synthetic N-acetyl-D-neuraminic acid does not raise concerns about its safety; it is intended to be marketed as an ingredient in formulae and foods for infants and young children as well as in food supplements for the general population; NANA is naturally present in human milk in both bound and free forms.
Clinical studies have demonstrated that Neu5Ac is safe and well tolerated as an ingredient in food supplements with no significant side effects.
Adverse Effects and Tolerability
The long-term safety profile of sialic acid supplements remains largely unknown due to limited clinical research. Digestive issues such as nausea, diarrhea, and stomach discomfort may arise in some individuals taking these supplements.
The Neu5Ac vs. Neu5Gc Distinction — A Critical Safety Consideration
An important safety nuance pertains not to Neu5Ac itself, but to its structural analog Neu5Gc (N-glycolylneuraminic acid). Neu5Gc is a non-human sialic acid capable of potentiating cancer and inflammation in the human body. Neu5Gc is notably deficient in humans due to a species-specific inactivating deletion in the CMAH gene; however, Neu5Gc is metabolically incorporated into human tissues from dietary sources, particularly red meat, and is detected at even higher levels in some human cancers; early-life exposure to Neu5Gc-containing foods can lead to generation of antibodies cross-reactive against Neu5Gc-containing glycans in human tissues.
Some reports show that Neu5Gc may promote inflammation, hepatocellular cancer, and hemolytic-uremic syndrome, while supplementation with Neu5Ac has been shown to promote brain development. It is essential to distinguish the human-native Neu5Ac from the non-human analog Neu5Gc when interpreting safety data; adverse effects reported for dietary sialic acids in some studies relate to Neu5Gc exposure from red meat, not to supplemental Neu5Ac.
Cancer Biology Considerations
The aberrant metabolism of Neu5Ac and its impact on breast cancer progression is receiving significant research attention. Cells treated with exogenous sialic acid showed improved motility, underwent metabolic reprogramming, and experienced a significant rise in the sialylation levels of key proteins. The implications of these in vitro findings for supplemental use in humans with cancer or elevated cancer risk are not yet established.
Potential Drug Interactions
Potential interactions with certain medications, such as immunosuppressants or those affecting neurological function, should be carefully evaluated. However, these considerations are based on theoretical mechanisms rather than documented clinical reports.
Summary of Evidence Gaps
The scientific literature collectively indicates that Neu5Ac is an endogenous, biologically essential molecule with a favorable safety profile at physiological concentrations. Long-term controlled clinical trials investigating supplemental Neu5Ac in healthy human adults are lacking. Most evidence for therapeutic applications (cognitive enhancement, anti-inflammatory effects, metabolic improvement) is derived from animal models and in vitro studies, requiring replication in well-powered human trials before firm clinical recommendations can be made.
References
Go back